{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:31:46Z","timestamp":1784611906597,"version":"3.55.0"},"posted":{"date-parts":[[2025,9,23]]},"group-title":"In Review","reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,9,15]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  The blood brain barrier and blood tumor barrier (BBB and BTB, respectively) represent significant obstacles for the delivery of drugs to treat diseases of the central nervous system, such as brain cancers and neurodegenerative diseases. Extracellular vesicles (EVs) or exosomes have emerged as a new drug delivery vehicle for CNS diseases as they may penetrate the BBB\/BTB and are less immunogenic than liposomal carriers. EVs derived from human neural stem cells (hNSC) provide additional benefits over other EV sources due to their increased homing capability to neural cells and demonstrated efficacy for treating stroke and traumatic brain injury in rodent models. However, the utilization of EVs from hNSC for drug delivery remains largely unexplored, due in part to difficulties in manufacturing capacity compared to traditional cell lines. Here, we report the development of a hNSC suspension neurosphere system for EV production and drug delivery. As proof of concept, doxorubicin was loaded into hNSC-EV, using a novel, high-efficiency alkaline passive loading method, and shown to be effective at inducing cytotoxicity in glioma cells\n                  <italic>in vitro<\/italic>\n                  and exhibiting higher BBB penetrance than doxorubicin-alone\n                  <italic>in vivo<\/italic>\n                  . These studies demonstrate the potential for hNSC-EV loaded doxorubicin as a therapeutic treatment for brain cancers such as glioblastoma, while also establishing hNSC-EVs as a drug-delivery vehicle for CNS diseases.\n                <\/p>","DOI":"10.21203\/rs.3.rs-7622911\/v1","type":"posted-content","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T06:33:46Z","timestamp":1758609226000},"source":"Crossref","is-referenced-by-count":0,"title":["Alkaline loading of extracellular vesicles produced from human neural stem cell-derived neurospheres enables CNS drug delivery"],"prefix":"10.21203","author":[{"given":"Amar M.","family":"Singh","sequence":"first","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"White","sequence":"additional","affiliation":[{"name":"Aruna Bio, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Phillips","sequence":"additional","affiliation":[{"name":"Aruna Bio, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan P.","family":"Crowe","sequence":"additional","affiliation":[{"name":"Aruna Bio, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Marti","sequence":"additional","affiliation":[{"name":"Aruna Bio, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan C.","family":"Finnerty","sequence":"additional","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martonio Ponte","family":"Viana","sequence":"additional","affiliation":[{"name":"Aruna Bio, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Antoniades","sequence":"additional","affiliation":[{"name":"Aruna Bio, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Martinez","sequence":"additional","affiliation":[{"name":"Aruna Bio, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Swetenburg","sequence":"additional","affiliation":[{"name":"Aruna Bio, Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Stice","sequence":"additional","affiliation":[{"name":"University of Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"12","key":"ref1","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s11064-009-0081-y","article-title":"Cellular elements of the blood-brain barrier","volume":"34","author":"Correale J","year":"2009","unstructured":"Correale, J. & Villa, A. Cellular elements of the blood-brain barrier. Neurochem Res. 34 (12), 2067\u20132077. 10.1007\/s11064-009-0081-y (2009).","journal-title":"Neurochem Res."},{"issue":"5","key":"ref2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen GC","year":"2021","unstructured":"Terstappen, G. C. et al. Strategies for delivering therapeutics across the blood-brain barrier. Nat. Rev. Drug Discov. 20 (5), 362\u2013383. 10.1038\/s41573-021-00139-y (2021).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"11","key":"ref3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41571-021-00529-6","article-title":"The blood-tumour barrier in cancer biology and therapy","volume":"18","author":"Steeg PS","year":"2021","unstructured":"Steeg, P. S. The blood-tumour barrier in cancer biology and therapy. Nat. Rev. Clin. Oncol. 18 (11), 696\u2013714. 10.1038\/s41571-021-00529-6 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges","volume":"12","author":"Pulgar VM","year":"2018","unstructured":"Pulgar, V. M. Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges. Front. Neurosci. 12, 1019. 10.3389\/fnins.2018.01019 (2018).","journal-title":"Front. Neurosci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jconrel.2019.01.005","article-title":"Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo","volume":"295","author":"Johnsen KB","year":"2019","unstructured":"Johnsen, K. B. et al. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo. J. Control Release. 295, 237\u2013249. 10.1016\/j.jconrel.2019.01.005 (2019).","journal-title":"J. Control Release"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.104.2.521","author":"Roberts RL","year":"1993","unstructured":"Roberts, R. L., Fine, R. E. & Sandra, A. Receptor-mediated endocytosis of transferrin at the blood-brain barrier. J Cell Sci, 104 (Pt 2): pp. 521\u2009\u2013\u200932. (1993). 10.1242\/jcs.104.2.521"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.145.1.123","article-title":"The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions","volume":"145","author":"Sheff DR","year":"1999","unstructured":"Sheff, D. R. et al. The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J. Cell. Biol. 145 (1), 123\u2013139. 10.1083\/jcb.145.1.123 (1999).","journal-title":"J. Cell. Biol."},{"issue":"84","key":"ref8","doi-asserted-by":"publisher","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu YJ","year":"2011","unstructured":"Yu, Y. J. et al. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci. Transl Med. 3 (84), 84ra44. 10.1126\/scitranslmed.3002230 (2011).","journal-title":"Sci. Transl Med."},{"issue":"21","key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111654","article-title":"Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?","volume":"22","author":"Pinheiro RGR","year":"2021","unstructured":"Pinheiro, R. G. R. et al. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know? Int. J. Mol. Sci. 22 (21). 10.3390\/ijms222111654 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"ref10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41578-020-00277-6","article-title":"Extracellular vesicles versus synthetic nanoparticles for drug delivery","volume":"6","author":"Witwer KW","year":"2021","unstructured":"Witwer, K. W. & Wolfram, J. Extracellular vesicles versus synthetic nanoparticles for drug delivery. Nat. Rev. Mater. 6 (2), 103\u2013106. 10.1038\/s41578-020-00277-6 (2021).","journal-title":"Nat. Rev. Mater."},{"issue":"12","key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124407","article-title":"Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation","volume":"21","author":"Banks WA","year":"2020","unstructured":"Banks, W. A. et al. Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. Int. J. Mol. Sci. 21 (12). 10.3390\/ijms21124407 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","article-title":"Extracellular vesicles through the blood-brain barrier: a review","volume":"19","author":"Ramos-Zaldivar HM","year":"2022","unstructured":"Ramos-Zaldivar, H. M. et al. Extracellular vesicles through the blood-brain barrier: a review. Fluids Barriers CNS. 19 (1), 60. 10.1186\/s12987-022-00359-3 (2022).","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"ref13","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1021\/acs.accounts.9b00109","article-title":"Drug Delivery with Extracellular Vesicles: From Imagination to Innovation","volume":"52","author":"Jong OG","year":"2019","unstructured":"de Jong, O. G. et al. Drug Delivery with Extracellular Vesicles: From Imagination to Innovation. Acc. Chem. Res. 52 (7), 1761\u20131770. 10.1021\/acs.accounts.9b00109 (2019).","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"ref14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann IK","year":"2021","unstructured":"Herrmann, I. K., Wood, M. J. A. & Fuhrmann, G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 16 (7), 748\u2013759. 10.1038\/s41565-021-00931-2 (2021).","journal-title":"Nat. Nanotechnol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.15212\/zoonoses-2022-0004","article-title":"Current understanding of extracellular vesicle homing\/tropism","volume":"2","author":"Edelmann MJ","year":"2022","unstructured":"Edelmann, M. J. & Kima, P. E. Current understanding of extracellular vesicle homing\/tropism. Zoonoses (Burlingt). 2 10.15212\/zoonoses-2022-0004 (2022).","journal-title":"Zoonoses (Burlingt)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"26316","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander OP","year":"2015","unstructured":"Wiklander, O. P. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles. 4, 26316. 10.3402\/jev.v4.26316 (2015).","journal-title":"J. Extracell. Vesicles"},{"issue":"7578","key":"ref17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino A","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527 (7578), 329\u2013335. 10.1038\/nature15756 (2015).","journal-title":"Nature"},{"issue":"5","key":"ref18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12975-017-0599-2","article-title":"Human Neural Stem Cell Extracellular Vesicles Improve Tissue and Functional Recovery in the Murine Thromboembolic Stroke Model","volume":"9","author":"Webb RL","year":"2018","unstructured":"Webb, R. L. et al. Human Neural Stem Cell Extracellular Vesicles Improve Tissue and Functional Recovery in the Murine Thromboembolic Stroke Model. Transl Stroke Res. 9 (5), 530\u2013539. 10.1007\/s12975-017-0599-2 (2018).","journal-title":"Transl Stroke Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neubiorev.2021.02.027","article-title":"Astrocyte-derived extracellular vesicles: A double-edged sword in central nervous system disorders","volume":"125","author":"Zhao S","year":"2021","unstructured":"Zhao, S. et al. Astrocyte-derived extracellular vesicles: A double-edged sword in central nervous system disorders. Neurosci. Biobehav. Rev. 125, 148\u2013159. 10.1016\/j.neubiorev.2021.02.027 (2021).","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/Eneuro.0148-24.2024","article-title":"Human Pluripotent Stem Cell-Derived Astrocyte Functionality Compares Favorably with Primary Rat Astrocytes","volume":"11","author":"Lendemeijer B","year":"2024","unstructured":"Lendemeijer, B. et al. Human Pluripotent Stem Cell-Derived Astrocyte Functionality Compares Favorably with Primary Rat Astrocytes. Eneuro 11 (9), 1\u201321. 10.1523\/Eneuro.0148-24.2024 (2024).","journal-title":"Eneuro"},{"issue":"1","key":"ref21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","article-title":"Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse","volume":"89","author":"Zhang Y","year":"2016","unstructured":"Zhang, Y. et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron 89 (1), 37\u201353. 10.1016\/j.neuron.2015.11.013 (2016).","journal-title":"Neuron"},{"issue":"5","key":"ref22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1432-0436.2007.00256.x","article-title":"Human neural progenitor cells derived from embryonic stem cells in feeder-free cultures","volume":"76","author":"Dhara SK","year":"2008","unstructured":"Dhara, S. K. et al. Human neural progenitor cells derived from embryonic stem cells in feeder-free cultures. Differentiation 76 (5), 454\u2013464. 10.1111\/j.1432-0436.2007.00256.x (2008).","journal-title":"Differentiation"},{"issue":"3","key":"ref23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jcb.21891","article-title":"Neural differentiation of human embryonic stem cells","volume":"105","author":"Dhara SK","year":"2008","unstructured":"Dhara, S. K. & Stice, S. L. Neural differentiation of human embryonic stem cells. J. Cell. Biochem. 105 (3), 633\u2013640. 10.1002\/jcb.21891 (2008).","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"ref24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1089\/scd.2005.14.266","article-title":"Human motor neuron differentiation from human embryonic stem cells","volume":"14","author":"Shin S","year":"2005","unstructured":"Shin, S., Dalton, S. & Stice, S. L. Human motor neuron differentiation from human embryonic stem cells. Stem Cells Dev. 14 (3), 266\u2013269. 10.1089\/scd.2005.14.266 (2005).","journal-title":"Stem Cells Dev."},{"issue":"1","key":"ref25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1634\/stemcells.2004-0150","article-title":"Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions","volume":"24","author":"Shin S","year":"2006","unstructured":"Shin, S. et al. Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells. 24 (1), 125\u2013138. 10.1634\/stemcells.2004-0150 (2006).","journal-title":"Stem Cells"},{"issue":"5","key":"ref26","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1634\/stemcells.2006-0660","article-title":"Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue","volume":"25","author":"Shin S","year":"2007","unstructured":"Shin, S. et al. Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue. Stem Cells. 25 (5), 1298\u20131306. 10.1634\/stemcells.2006-0660 (2007).","journal-title":"Stem Cells"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12015-006-0011-1","article-title":"Development and differentiation of neural rosettes derived from human embryonic stem cells","volume":"2","author":"Wilson PG","year":"2006","unstructured":"Wilson, P. G. & Stice, S. S. Development and differentiation of neural rosettes derived from human embryonic stem cells. Stem Cell. Rev. 2 (1), 67\u201377. 10.1007\/s12015-006-0011-1 (2006).","journal-title":"Stem Cell. Rev."},{"issue":"6","key":"ref28","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.14336\/AD.2021.0708","article-title":"Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles","volume":"12","author":"Jurgielewicz B","year":"2021","unstructured":"Jurgielewicz, B., Stice, S. & Yao, Y. Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles. Aging Dis. 12 (6), 1476\u20131493. 10.14336\/AD.2021.0708 (2021).","journal-title":"Aging Dis."},{"issue":"4","key":"ref29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s12975-019-00753-4","article-title":"Neural Stem Cell Extracellular Vesicles Disrupt Midline Shift Predictive Outcomes in Porcine Ischemic Stroke Model","volume":"11","author":"Spellicy SE","year":"2020","unstructured":"Spellicy, S. E. et al. Neural Stem Cell Extracellular Vesicles Disrupt Midline Shift Predictive Outcomes in Porcine Ischemic Stroke Model. Transl Stroke Res. 11 (4), 776\u2013788. 10.1007\/s12975-019-00753-4 (2020).","journal-title":"Transl Stroke Res."},{"issue":"11","key":"ref30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1089\/neu.2019.6443","article-title":"Extracellular Vesicles Mediate Neuroprotection and Functional Recovery after Traumatic Brain Injury","volume":"37","author":"Sun MK","year":"2020","unstructured":"Sun, M. K. et al. Extracellular Vesicles Mediate Neuroprotection and Functional Recovery after Traumatic Brain Injury. J. Neurotrauma. 37 (11), 1358\u20131369. 10.1089\/neu.2019.6443 (2020).","journal-title":"J. Neurotrauma"},{"issue":"5","key":"ref31","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/STROKEAHA.117.020353","article-title":"Human Neural Stem Cell Extracellular Vesicles Improve Recovery in a Porcine Model of Ischemic Stroke","volume":"49","author":"Webb RL","year":"2018","unstructured":"Webb, R. L. et al. Human Neural Stem Cell Extracellular Vesicles Improve Recovery in a Porcine Model of Ischemic Stroke. Stroke 49 (5), 1248\u20131256. 10.1161\/STROKEAHA.117.020353 (2018).","journal-title":"Stroke"},{"issue":"4","key":"ref32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cbpa.2007.05.034","article-title":"Bioreactor development for stem cell expansion and controlled differentiation","volume":"11","author":"King JA","year":"2007","unstructured":"King, J. A. & Miller, W. M. Bioreactor development for stem cell expansion and controlled differentiation. Curr. Opin. Chem. Biol. 11 (4), 394\u2013398. 10.1016\/j.cbpa.2007.05.034 (2007).","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s42003-020-01218-3","article-title":"Stirred suspension bioreactors maintain naive pluripotency of human pluripotent stem cells","volume":"3","author":"Rohani L","year":"2020","unstructured":"Rohani, L. et al. Stirred suspension bioreactors maintain naive pluripotency of human pluripotent stem cells. Commun. Biol. 3 (1), 492. 10.1038\/s42003-020-01218-3 (2020).","journal-title":"Commun. Biol."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12533.1","author":"Stephenson M","year":"2018","unstructured":"Stephenson, M. & Grayson, W. Recent advances in bioreactors for cell-based therapies. F1000Res, 7. (2018). 10.12688\/f1000research.12533.1"},{"issue":"1","key":"ref35","doi-asserted-by":"publisher","first-page":"22069","DOI":"10.1038\/s41598-024-73074-8","article-title":"Identification of blood lipid markers of docetaxel treatment in prostate cancer patients","volume":"14","author":"Finnerty MC","year":"2024","unstructured":"Finnerty, M. C. et al. Identification of blood lipid markers of docetaxel treatment in prostate cancer patients. Sci. Rep. 14 (1), 22069. 10.1038\/s41598-024-73074-8 (2024).","journal-title":"Sci. Rep."},{"issue":"4","key":"ref36","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ac7eeb","article-title":"Scale-out production of extracellular vesicles derived from natural killer cells via mechanical stimulation in a seesaw-motion bioreactor for cancer therapy","volume":"14","author":"Wu J","year":"2022","unstructured":"Wu, J. et al. Scale-out production of extracellular vesicles derived from natural killer cells via mechanical stimulation in a seesaw-motion bioreactor for cancer therapy. Biofabrication 14 (4). 10.1088\/1758-5090\/ac7eeb (2022).","journal-title":"Biofabrication"},{"issue":"1\u20132","key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.01.002","article-title":"Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations","volume":"519","author":"Luo R","year":"2017","unstructured":"Luo, R. et al. Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations. Int. J. Pharm. 519 (1\u20132), 1\u201310. 10.1016\/j.ijpharm.2017.01.002 (2017).","journal-title":"Int. J. Pharm."},{"issue":"6","key":"ref38","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1088\/0031-9155\/60\/6\/2511","article-title":"Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model","volume":"60","author":"Aryal M","year":"2015","unstructured":"Aryal, M. et al. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model. Phys. Med. Biol. 60 (6), 2511\u20132527. 10.1088\/0031-9155\/60\/6\/2511 (2015).","journal-title":"Phys. Med. Biol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jconrel.2014.05.033","article-title":"Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models","volume":"187","author":"Kovacs Z","year":"2014","unstructured":"Kovacs, Z. et al. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J. Control Release. 187, 74\u201382. 10.1016\/j.jconrel.2014.05.033 (2014).","journal-title":"J. Control Release"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2147\/IJN.S29229","article-title":"Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound","volume":"7","author":"Yang FY","year":"2012","unstructured":"Yang, F. Y. et al. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound. Int. J. Nanomed. 7, 965\u2013974. 10.2147\/IJN.S29229 (2012).","journal-title":"Int. J. Nanomed."},{"issue":"19","key":"ref41","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/rcm.6671","article-title":"A rapid analytical method for the quantification of paclitaxel in rat plasma and brain tissue by high-performance liquid chromatography and tandem mass spectrometry","volume":"27","author":"Li P","year":"2013","unstructured":"Li, P. et al. A rapid analytical method for the quantification of paclitaxel in rat plasma and brain tissue by high-performance liquid chromatography and tandem mass spectrometry. Rapid Commun. Mass. Spectrom. 27 (19), 2127\u20132134. 10.1002\/rcm.6671 (2013).","journal-title":"Rapid Commun. Mass. Spectrom."},{"issue":"7","key":"ref42","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00216-022-04248-4","article-title":"Single-particle assessment of six different drug-loading strategies for incorporating doxorubicin into small extracellular vesicles","volume":"415","author":"Chen C","year":"2023","unstructured":"Chen, C. et al. Single-particle assessment of six different drug-loading strategies for incorporating doxorubicin into small extracellular vesicles. Anal. Bioanal Chem. 415 (7), 1287\u20131298. 10.1007\/s00216-022-04248-4 (2023).","journal-title":"Anal. Bioanal Chem."},{"issue":"3","key":"ref43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11481-019-09884-9","article-title":"Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy","volume":"15","author":"Haney MJ","year":"2020","unstructured":"Haney, M. J. et al. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. J. Neuroimmune Pharmacol. 15 (3), 487\u2013500. 10.1007\/s11481-019-09884-9 (2020).","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"ref44","doi-asserted-by":"publisher","first-page":"e0214545","DOI":"10.1371\/journal.pone.0214545","article-title":"Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency","volume":"14","author":"Schindler C","year":"2019","unstructured":"Schindler, C. et al. Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency. PLoS One. 14 (3), e0214545. 10.1371\/journal.pone.0214545 (2019).","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jconrel.2021.07.004","article-title":"Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison","volume":"336","author":"Wu JY","year":"2021","unstructured":"Wu, J. Y. et al. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison. J. Control Release. 336, 510\u2013521. 10.1016\/j.jconrel.2021.07.004 (2021).","journal-title":"J. Control Release"},{"issue":"1","key":"ref46","doi-asserted-by":"publisher","first-page":"2237134","DOI":"10.1080\/09537104.2023.2237134","article-title":"Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization","volume":"34","author":"Wu YW","year":"2023","unstructured":"Wu, Y. W. et al. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization. Platelets 34 (1), 2237134. 10.1080\/09537104.2023.2237134 (2023).","journal-title":"Platelets"},{"issue":"12","key":"ref47","doi-asserted-by":"publisher","first-page":"13283","DOI":"10.1007\/s12274-023-5921-6","article-title":"Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety","volume":"16","author":"Zhou Y","year":"2023","unstructured":"Zhou, Y. et al. Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety. Nano Res. 16 (12), 13283\u201313293. 10.1007\/s12274-023-5921-6 (2023).","journal-title":"Nano Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"553444","DOI":"10.3389\/fcell.2020.553444","article-title":"Scalable Production of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Under Serum-\/Xeno-Free Conditions in a Microcarrier-Based Bioreactor Culture System","volume":"8","author":"Almeida Fuzeta M","year":"2020","unstructured":"de Almeida Fuzeta, M. et al. Scalable Production of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Under Serum-\/Xeno-Free Conditions in a Microcarrier-Based Bioreactor Culture System. Front. Cell. Dev. Biol. 8, 553444. 10.3389\/fcell.2020.553444 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6409346","author":"Abedi M","year":"2022","unstructured":"Abedi, M. et al. Exosome Derived from Human Neural Stem Cells Improves Motor Activity and Neurogenesis in a Traumatic Brain Injury Model. Biomed Res Int, 2022: p. 6409346. (2022). 10.1155\/2022\/6409346"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05848-x","author":"Branscome H","year":"2022","unstructured":"Branscome, H. et al. Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage. Sci Rep, 12(1): p. 2019. (2022). 10.1038\/s41598-022-05848-x"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-1783-0_8","article-title":"Method for Isolating Extracellular Vesicles from Human Neural Stem Cells Expanded Under Neurosphere Culture","volume":"2389","author":"Koopaei NN","year":"2022","unstructured":"Koopaei, N. N. et al. Method for Isolating Extracellular Vesicles from Human Neural Stem Cells Expanded Under Neurosphere Culture. Methods Mol. Biol. 2389, 87\u201394. 10.1007\/978-1-0716-1783-0_8 (2022).","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"ref52","doi-asserted-by":"publisher","first-page":"e1801082","DOI":"10.1002\/adhm.201801082","article-title":"Extracellular Vesicle-Mimetic Ghost Nanovesicles for Delivering Anti-Inflammatory Drugs to Mitigate Gram-Negative Bacterial Outer Membrane Vesicle-Induced Systemic Inflammatory Response Syndrome","volume":"8","author":"Go G","year":"2019","unstructured":"Go, G. et al. Extracellular Vesicle-Mimetic Ghost Nanovesicles for Delivering Anti-Inflammatory Drugs to Mitigate Gram-Negative Bacterial Outer Membrane Vesicle-Induced Systemic Inflammatory Response Syndrome. Adv. Healthc. Mater. 8 (4), e1801082. 10.1002\/adhm.201801082 (2019).","journal-title":"Adv. Healthc. Mater."},{"issue":"6","key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060802","article-title":"Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting","volume":"16","author":"Lee J","year":"2023","unstructured":"Lee, J., Choi, M. K. & Song, I. S. Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting. Pharmaceuticals (Basel). 16 (6). 10.3390\/ph16060802 (2023).","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"115612","DOI":"10.1016\/j.ejmech.2023.115612","article-title":"Doxorubicin prodrug-based nanomedicines for the treatment of cancer","volume":"258","author":"Zhao H","year":"2023","unstructured":"Zhao, H. et al. Doxorubicin prodrug-based nanomedicines for the treatment of cancer. Eur. J. Med. Chem. 258, 115612. 10.1016\/j.ejmech.2023.115612 (2023).","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"ref55","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1089\/ten.tea.2009.0155","article-title":"Genetic manipulation of neural progenitors derived from human embryonic stem cells","volume":"15","author":"Dhara SK","year":"2009","unstructured":"Dhara, S. K. et al. Genetic manipulation of neural progenitors derived from human embryonic stem cells. Tissue Eng. Part. A. 15 (11), 3621\u20133634. 10.1089\/ten.tea.2009.0155 (2009).","journal-title":"Tissue Eng. Part. A"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7622911\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7622911\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:04:32Z","timestamp":1782144272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7622911\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":55,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7622911\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-026-58290-8","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,9,23]]},"subtype":"preprint"}}